HUMA Stock Summary and Trading Ideas (Humacyte | NASDAQ:HUMA)

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

What symbol and exchange does Humacyte shares trade?

Humacyte trades on the NASDAQ stock market under the symbol HUMA.

What is Humacyte stock price doing today?

As of May 29, 2026, HUMA stock price climbed to $1.30 with 9,088,518 million shares trading.

What is Humacyte's Beta?

HUMA has a beta of 3.64, meaning it tends to be more sensitive to market movements. HUMA has a correlation of 0.20 to the broad based SPY ETF.

How much is Humacyte worth?

HUMA has a market cap of $288.62 million. This is considered a Small Cap stock.

How much money does Humacyte make?

Last quarter Humacyte reported $495,000 in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-922,600 and exceeded earnings estimates by $.02.

What is the highest and lowest price Humacyte traded in the last 3 year period?

In the last 3 years, HUMA traded as high as $9.97 and as low as $.55.

What are the top ETFs holding Humacyte?

The top ETF exchange traded funds that HUMA belongs to (by Net Assets): IWM, VTI, IBB, VXF, IWN.

Is Humacyte (HUMA) a good investment?

HUMA has underperformed the market in the last year with a return of -53.1%, while SPY returned +29.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HUMA shares. However, HUMA has outperformed the market in the last 3 month and 2 week periods, returning +16.6% and +39.8%, while SPY returned +10.5% and +2.3%, respectively. This indicates HUMA has been having a stronger performance recently.

What are the support and resistance levels for Humacyte (HUMA)?

HUMA support price is $1.18 and resistance is $1.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUMA shares will trade within this expected range on the day.